Vesselon Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

  Guildford, UK - 29 April 2021: Ergomed plc (LSE: ERGO) ( Ergomed or the Company ), a company focused on providing specialised services to the pharmaceutical industry, today announces that Dr. Llew Keltner, M.D., Ph.D., will join the Board as a Non-Executive Director with immediate effect. The Company also announces that Non-Executive Director, Ian Johnson, is stepping down from the Ergomed Board to focus on his other Board roles.   Dr. Keltner brings over 30 years of experience across the life sciences sector, holding various senior positions with a particular focus on oncology and rare diseases. He has extensive experience of public and private financings, M&A, the formation of strategic partnerships and numerous transactions in the CRO, biotech and pharma sectors. While Chairman of Raptor Pharmaceuticals Inc., a US rare disease company, he led multiple financing rounds, product launches and the eventual sale of the Company to Horizon Phar

United kingdomUnited statesRichard barfieldBrian johnsonFreddie barnfield matthew odowdAngela gray olivia manserMiroslav reljanoviChris gardner matthew nealSurgeon training internationalCompany to horizon pharmaceuticalsLight sciences oncologyVesselon incYk bioImmunovaccine incInfostat systems incRaptor pharmaceuticals inc